⌘K
Loading ticker…
As of 2026-08-21, Barinthus Biotherapeutics plc American Depositary Shares (BRNS) has a 3-month relative strength percentile of 29 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.2%, relative volume 0.35×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
BRNS is in a stage 4 downtrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -0.4% / -7.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BRNS Jan avg: -10.18% median: -9.33% win: 33% σ: 14.89% n: 3 2023-11-08 → 2026-07-31 | BRNS Feb avg: -8.29% median: -7.79% win: 33% σ: 11.46% n: 3 2023-11-08 → 2026-07-31 | BRNS Mar avg: -7.39% median: -3.69% win: 0% σ: 7.39% n: 3 2023-11-08 → 2026-07-31 | BRNS Apr avg: 5.17% median: 14.24% win: 67% σ: 16.49% n: 3 2023-11-08 → 2026-07-31 | BRNS May avg: -1.89% median: -3.57% win: 33% σ: 5.96% n: 3 2023-11-08 → 2026-07-31 | BRNS Jun avg: -14.54% median: -13.88% win: 0% σ: 11.84% n: 3 2023-11-08 → 2026-07-31 | BRNS Jul avg: 16.69% median: 6.43% win: 67% σ: 38.35% n: 3 2023-11-08 → 2026-07-31 | BRNS Aug avg: -18.04% median: -18.04% win: 0% σ: 8.89% n: 2 2023-11-08 → 2026-07-31 (current) | BRNS Sep avg: 1.05% median: 1.05% win: 50% σ: 14.93% n: 2 2023-11-08 → 2026-07-31 | BRNS Oct avg: 15.29% median: 15.29% win: 100% σ: 14.04% n: 2 2023-11-08 → 2026-07-31 | BRNS Nov avg: -34.74% median: -33.84% win: 0% σ: 4.89% n: 3 2023-11-08 → 2026-07-31 | BRNS Dec avg: 13.47% median: 22.54% win: 67% σ: 21.78% n: 3 2023-11-08 → 2026-07-31 |